Search International and National Patent Collections

1. (WO2018135932) COMPLEX FORMULATION COMPRISING HMG-COA REDUCTASE INHIBITOR AND CLOPIDOGREL

Pub. No.:    WO/2018/135932    International Application No.:    PCT/KR2018/001033
Publication Date: Fri Jul 27 01:59:59 CEST 2018 International Filing Date: Wed Jan 24 00:59:59 CET 2018
IPC: A61K 9/24
A61K 9/20
A61K 31/4365
A61K 31/505
A61K 45/06
Applicants: DONG WHA PHARM. CO., LTD.
동화약품주식회사
Inventors: BAEK, Nam Hyun
백남현
CHOI, Min Soo
최민수
KIM, Ja Young
김자영
WOO, Ji Young
우지영
SEONG, Seung Kyoo
성승규
SONG, Young Jun
송영준
SEO, Ki Soo
서기수
HEO, Woon
허운
JUNG, Taeseong
정태성
Title: COMPLEX FORMULATION COMPRISING HMG-COA REDUCTASE INHIBITOR AND CLOPIDOGREL
Abstract:
The present invention relates to a complex formulation comprising clopidogrel, an HMG-CoA reductase inhibitor, and a membrane containing a hydrophobic compound. More specifically, the objective of the present invention is to provide a complex formulation comprising clopidogrel and an HMG-CoA reductase inhibitor, the complex formulation for prevention or treatment of cardiovascular diseases, which is excellent in storage stability by preventing degradation of the stability of an HMG-CoA reductase inhibitor.